3-14148737-T-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004628.5(XPC):​c.2251-6A>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.612 in 1,613,516 control chromosomes in the GnomAD database, including 304,401 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.64 ( 31584 hom., cov: 32)
Exomes 𝑓: 0.61 ( 272817 hom. )

Consequence

XPC
NM_004628.5 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00004812
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0560
Variant links:
Genes affected
XPC (HGNC:12816): (XPC complex subunit, DNA damage recognition and repair factor) The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017]
XPC-AS1 (HGNC:55014): (XPC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-14148737-T-G is Benign according to our data. Variant chr3-14148737-T-G is described in ClinVar as [Benign]. Clinvar id is 190214.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.698 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
XPCNM_004628.5 linkuse as main transcriptc.2251-6A>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000285021.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
XPCENST00000285021.12 linkuse as main transcriptc.2251-6A>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_004628.5 P1Q01831-1
XPC-AS1ENST00000627116.2 linkuse as main transcriptn.300+36T>G intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.642
AC:
97494
AN:
151914
Hom.:
31541
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.705
Gnomad AMI
AF:
0.641
Gnomad AMR
AF:
0.668
Gnomad ASJ
AF:
0.533
Gnomad EAS
AF:
0.637
Gnomad SAS
AF:
0.656
Gnomad FIN
AF:
0.700
Gnomad MID
AF:
0.484
Gnomad NFE
AF:
0.594
Gnomad OTH
AF:
0.641
GnomAD3 exomes
AF:
0.633
AC:
157405
AN:
248834
Hom.:
50207
AF XY:
0.626
AC XY:
84558
AN XY:
135002
show subpopulations
Gnomad AFR exome
AF:
0.709
Gnomad AMR exome
AF:
0.705
Gnomad ASJ exome
AF:
0.530
Gnomad EAS exome
AF:
0.640
Gnomad SAS exome
AF:
0.648
Gnomad FIN exome
AF:
0.698
Gnomad NFE exome
AF:
0.593
Gnomad OTH exome
AF:
0.603
GnomAD4 exome
AF:
0.609
AC:
890414
AN:
1461484
Hom.:
272817
Cov.:
84
AF XY:
0.608
AC XY:
442169
AN XY:
726988
show subpopulations
Gnomad4 AFR exome
AF:
0.707
Gnomad4 AMR exome
AF:
0.702
Gnomad4 ASJ exome
AF:
0.529
Gnomad4 EAS exome
AF:
0.618
Gnomad4 SAS exome
AF:
0.646
Gnomad4 FIN exome
AF:
0.692
Gnomad4 NFE exome
AF:
0.598
Gnomad4 OTH exome
AF:
0.603
GnomAD4 genome
AF:
0.642
AC:
97611
AN:
152032
Hom.:
31584
Cov.:
32
AF XY:
0.648
AC XY:
48128
AN XY:
74294
show subpopulations
Gnomad4 AFR
AF:
0.705
Gnomad4 AMR
AF:
0.668
Gnomad4 ASJ
AF:
0.533
Gnomad4 EAS
AF:
0.637
Gnomad4 SAS
AF:
0.658
Gnomad4 FIN
AF:
0.700
Gnomad4 NFE
AF:
0.594
Gnomad4 OTH
AF:
0.644
Alfa
AF:
0.608
Hom.:
12795
Bravo
AF:
0.642
Asia WGS
AF:
0.677
AC:
2354
AN:
3478
EpiCase
AF:
0.570
EpiControl
AF:
0.573

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxJan 10, 2019This variant is associated with the following publications: (PMID: 12177305, 19027756, 21559836, 10766188) -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2023XPC: BP4, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 19, 2017Variant summary: The XPC c.2251-6A>C variant involves the alteration of a non-conserved intronic nucleotide and 4/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 75910/120462 control chromosomes (24122 homozygotes) at a frequency of 0.6301572, which is approximately 446 times the estimated maximal expected allele frequency of a pathogenic XPC variant (0.0014142). The observed frequency indicate that the C allele is the major allele observed in the general population. In addition, multiple clinical diagnostic laboratories classified this variant as benign. Taken together, this variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingClaritas GenomicsJun 20, 2012- -
Xeroderma pigmentosum, group C Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabDec 05, 2021- -
Xeroderma pigmentosum group A Benign:1
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.9
DANN
Benign
0.53
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000048
dbscSNV1_RF
Benign
0.046
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2279017; hg19: chr3-14190237; COSMIC: COSV53203698; COSMIC: COSV53203698; API